HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metastatic focal infections due to multiresistant Salmonella typhimurium in children: a 34 month experience in Rwanda.

Abstract
Nineteen out of 139 children with severe systemic disease due to multiresistant Salmonella typhimurium observed during a 34-month period in an in-patient department in Rwanda had focal metastatic infections. More than 80% of the invasive Salmonella infections were acquired in the hospital. Focal metastatic infections occurred after longer hospital stays than bacteremia (29.1 +/- 17.4 days as against 13.5 +/- 9.0 days, p less than 0.01) and were diagnosed more time after the first sign of infection (3.28 +/- 1.41 days as against 1.86 +/- 1.10 days, p less than 0.01). Bacteremia was documented in 13 of the 17 children with focal infection from whom blood cultures were obtained. Seven of 12 had positive stool cultures. The sites of metastatic focal infection were meninges (7 cases), soft tissue (5 cases), joint or bone (4 cases), pleura (2 cases), eye (1 case). The clinical course of meningitis was fulminant and 6/7 patients died before receiving adequate antimicrobial therapy. One child with meningitis and 9 patients with focal infections at other sites were treated with cefotaxime and were cured or improved.
AuthorsP Lepage, J Bogaerts, F Nsengumuremyi, C Van Goethem, D G Hitimana, J Vandepitte, J P Butzler, J Levy
JournalEuropean journal of epidemiology (Eur J Epidemiol) Vol. 2 Issue 2 Pg. 99-103 (Jun 1986) ISSN: 0393-2990 [Print] Netherlands
PMID3533612 (Publication Type: Journal Article)
Topics
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Focal Infection (epidemiology, microbiology)
  • Humans
  • Infant
  • Infant, Newborn
  • Meningitis (epidemiology, microbiology)
  • Rwanda
  • Salmonella Infections (epidemiology)
  • Salmonella typhimurium (drug effects)
  • Sepsis (epidemiology, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: